News : distribution agreement

Moberg Derma AB (publ.) and Alterna LLC have entered into a distribution and cooperation agreement for Emtrix® – a treatment of discolored and damaged nails caused by nail fungus (onychomycosis) or nail psoriasis.  Under the agreement Alterna receives exclusive rights to sell Emtrix® in the U.S. and assumes responsibility for sales and marketing activities.  Moberg Derma assumes production and supply responsibility....

Uppsala, February 17, 2010

Orexo AB (publ) –
Year-end Report January–December 2009



Key events during the year
• Net revenues totaled MSEK 236.1 (233.3).
• The loss after tax was MSEK 98.1 (loss: 103.1).
• The loss per share amounted to a loss of SEK 4.32 (loss: 4.77).
• Cash and cash equivalents at year-end totaled MSEK 87.4 (188.2).
• Abstral was launched in UK, Germany, France, Spain and Greece.
• In March,...

Uppsala, February 2, 2010 – Orexo AB (STO: ORX) announces today that its partner Kyowa Hakko Kirin Co., Ltd. has entered a joint distribution agreement for the cancer pain drug KW-2246 (Orexo’s sublingual fentanyl product) with the pharmaceutical company Hisamitsu Pharmaceutical Co., Inc.

Kyowa Hakko Kirin is responsible for the approval process for the product in Japan and under the terms of the agreement, KW-2246...